Patents by Inventor Laura A. Rudolph-Owen

Laura A. Rudolph-Owen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030040474
    Abstract: The invention provides isolated nucleic acids molecules, designated 32229 nucleic acid molecules, which encode novel acyl-CoA dehydrogenase members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 32229 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 32229 gene has been introduced or disrupted. The invention still further provides isolated 32229 proteins, fusion proteins, antigenic peptides and anti-32229 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: October 22, 2001
    Publication date: February 27, 2003
    Inventors: Rosana Kapeller-Libermann, John J. Hunter, Laura A. Rudolph-Owen
  • Publication number: 20030037350
    Abstract: The invention provides isolated nucleic acids molecules that encode novel polypeptides. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing the nucleic acid molecules of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a sequence of the invention has been introduced or disrupted. The invention still further provides isolated proteins, fusion proteins, antigenic peptides and antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: June 5, 2002
    Publication date: February 20, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Maria Alexandra Glucksmann, Rosana Kapeller-Libermann, Rachel E. Meyers, Laura A. Rudolph-Owen
  • Publication number: 20030017539
    Abstract: The invention provides isolated nucleic acids molecules that encode novel polypeptides. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing the nucleic acid molecules of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a sequence of the invention has been introduced or disrupted. The invention still further provides isolated proteins, fusion proteins, antigenic peptides and antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: June 7, 2002
    Publication date: January 23, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Maria Alexandra Glucksmann, Martin R. Hodge, John J. Hunter, Laura A. Rudolph-Owen, Inmaculada Silos-Santiago, Nadine S. Weich
  • Publication number: 20020164750
    Abstract: The invention provides isolated nucleic acids molecules, designated 56634 nucleic acid molecules, which encode novel phosphatidylinositol 4-phosphate 5-kinase members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 56634 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 56634 gene has been introduced or disrupted. The invention still further provides isolated 56634 proteins, fusion proteins, antigenic peptides and anti-56634 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: November 13, 2001
    Publication date: November 7, 2002
    Inventors: Rachel E. Meyers, Laura A. Rudolph-Owen
  • Publication number: 20020164769
    Abstract: The invention provides isolated nucleic acids molecules, designated 32144 nucleic acid molecules, which encode novel fatty acid amide hydrolase members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 32144 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 32144 gene has been introduced or disrupted. The invention still further provides isolated 32144 proteins, fusion proteins, antigenic peptides and anti-32144 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: September 27, 2001
    Publication date: November 7, 2002
    Inventors: Rory A.J. Curtis, Kyle J. MacBeth, Laura A. Rudolph-Owen
  • Patent number: 6458576
    Abstract: The invention provides isolated nucleic acids molecules, designated 22406 nucleic acid molecules, which encode a novel pyridoxal-phosphate dependent serine racemase. In particular, the invention relates to 22406 serine racemase polypeptide and encoding nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 22406 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 22406 gene has been introduced or disrupted. The invention still further provides isolated 22406 proteins, fusion proteins, antigenic peptides and anti-22406 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: October 1, 2002
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Rachel A. Meyers, Laura A. Rudolph-Owen
  • Publication number: 20020119466
    Abstract: The invention provides isolated nucleic acid molecules, designated TPRM nucleic acid molecules, which encode novel methyltransferase family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing TPRM nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a TPRM gene has been introduced or disrupted. The invention still further provides isolated TPRM proteins, fusion proteins, antigenic peptides and anti-TPRM antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: August 24, 2001
    Publication date: August 29, 2002
    Inventors: Rachel Meyers, Mark Williamson, Laura A. Rudolph-Owen
  • Publication number: 20020115137
    Abstract: The invention provides isolated nucleic acids molecules, designated 22406 nucleic acid molecules, which encode a novel pyridoxal-phosphate dependent enzyme family member. In particular, the invention relates to 22406 serine racemase polypeptide and encoding nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 22406 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 22406 gene has been introduced or disrupted. The invention still further provides isolated 22406 proteins, fusion proteins, antigenic peptides and anti-22406 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: February 20, 2001
    Publication date: August 22, 2002
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Rachel A. Meyers, Laura A. Rudolph-Owen
  • Publication number: 20020115120
    Abstract: Novel HKID-1 polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length HKID-1 proteins, the invention further provides isolated HKID-1 fusion proteins, antigenic peptides and anti-HKID-1 antibodies. The invention also provides HKID-1 nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which an HKID-1 gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: October 4, 2001
    Publication date: August 22, 2002
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Rosana Kapeller-Libermann, Laura A. Rudolph-Owen, Kyle MacBeth
  • Publication number: 20020111307
    Abstract: The invention provides isolated nucleic acids molecules, designated 46508 nucleic acid molecules, which encode novel peptidyl-tRNA hydrolase members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 46508 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 46508 gene has been introduced or disrupted. The invention still further provides isolated 46508 proteins, fusion proteins, antigenic peptides and anti-46508 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: June 25, 2001
    Publication date: August 15, 2002
    Inventors: Maria Alexandra Glucksmann, Laura A. Rudolph-Owen
  • Publication number: 20020068698
    Abstract: The invention provides isolated nucleic acids molecules, designated 13237, 18480, 2245 or 16228 nucleic acid molecules, which encode novel protein kinase family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 13237, 18480, 2245 or 16228 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 13237, 18480, 2245 or 16228 gene has been introduced or disrupted. The invention still further provides isolated 13237, 18480, 2245 or 16228 proteins, fusion proteins, antigenic peptides and anti-13237, -18480, -2245 or -16228 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: July 18, 2001
    Publication date: June 6, 2002
    Inventors: Rachel Meyers, Laura A. Rudolph-Owen, Rosana Kapeller-Libermann, Fong Ying Tsai
  • Publication number: 20020052032
    Abstract: The invention provides isolated nucleic acids molecules, designated DHDR nucleic acid molecules, which encode novel DHDR-related dehydrogenase molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing DHDR nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a DHDR gene has been introduced or disrupted. The invention still further provides isolated DHDR proteins, fusion proteins, antigenic peptides and anti-DHDR antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: March 23, 2001
    Publication date: May 2, 2002
    Inventors: Rachel Meyers, William James Cook, Mark Williamson, Laura A. Rudolph-Owen
  • Publication number: 20020042371
    Abstract: The invention provides isolated nucleic acids molecules, designated DHDR nucleic acid molecules, which encode novel DHDR-related dehydrogenase molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing DHDR nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a DHDR gene has been introduced or disrupted. The invention still further provides isolated DHDR proteins, fusion proteins, antigenic peptides and anti-DHDR antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: April 18, 2001
    Publication date: April 11, 2002
    Inventors: Rachel Meyers, William James Cook, Mark Williamson, Laura A. Rudolph-Owen, Ruth Gimeno
  • Publication number: 20020034783
    Abstract: The invention provides isolated nucleic acids molecules, designated Adhr-1 nucleic acid molecules, which encode a novel family of alcohol dehydrogenase (Adh) proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing Adhr-1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an Adhr-1 gene has been introduced or disrupted. The invention still further provides isolated Adhr-1 proteins, fusion proteins, antigenic peptides, and anti-Adhr-1 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: April 18, 2001
    Publication date: March 21, 2002
    Inventors: Rachel Meyers, Laura A. Rudolph-Owen
  • Publication number: 20020019030
    Abstract: The invention provides isolated nucleic acids molecules, designated transferase nucleic acid molecules, which encode novel transferase family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing transferase nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a transferase gene has been introduced or disrupted. The invention still further provides isolated transferase proteins, fusion proteins, antigenic peptides and anti-transferase antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: February 27, 2001
    Publication date: February 14, 2002
    Inventors: Rachel Meyers, Kyle J. MacBeth, Laura Rudolph-Owen
  • Publication number: 20020016449
    Abstract: The invention provides isolated nucleic acids molecules, designated 46743 or 27417 nucleic acid molecules, which encode novel acyltransferase family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 46743 or 27417 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 46743 or 27417 gene has been introduced or disrupted. The invention still further provides isolated 46743 or 27417 proteins, fusion proteins, antigenic peptides and anti-46743 or anti-27417 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: March 26, 2001
    Publication date: February 7, 2002
    Inventors: Rachel A. Meyers, Kyle J. Macbeth, Mark Williamson, Laura A. Rudolph-Owen, Fong-Ying Tsai
  • Publication number: 20020001807
    Abstract: The invention provides isolated nucleic acids molecules, designated 21509 or 33770 nucleic acid molecules, which encode novel dehydrogenase members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 21509 or 33770 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 21509 or 33770 gene has been introduced or disrupted. The invention still further provides isolated 21509 or 33770 proteins, fusion proteins, antigenic peptides and anti-21509 or 33770 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: March 30, 2001
    Publication date: January 3, 2002
    Inventors: Rachel A. Meyers, Laura A. Rudolph-Owen
  • Publication number: 20010036649
    Abstract: Novel cytidine deaminase-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length cytidine deaminase-like proteins, the invention further provides isolated cytidine deaminase-like fusion proteins, antigenic peptides, and anti-cytidine deaminase-like antibodies. The invention also provides cytidine deaminase-like nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an cytidine deaminase-like gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: March 9, 2001
    Publication date: November 1, 2001
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Rachel A. Meyers, Laura A. Rudolph-Owen